The field of molecular diagnostics is undergoing a paradigm shift. Traditional methods, while effective, often lack the speed and sensitivity required for next-generation point-of-care testing. My research at École Normale Supérieure focused on bridging this gap using supramolecular assemblies.
The Challenge of Single-Point Mutations
Detecting single-point mutations in short DNA sequences is notoriously difficult. Standard PCR methods can struggle with specificity when the target variance is so minimal. This is where supramolecular chemistry offers a unique solution.
A New Approach
By utilizing specific supramolecular assemblies, we can create systems that "light up" only in the presence of the exact target sequence. This method allows for:
- Higher specificity than traditional probes
- Rapid detection times
- Potential for multiplexing without complex equipment
This technology has the potential to revolutionize how we approach personalized diagnostics, making genetic screening more accessible and accurate than ever before.